Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization. - Aix-Marseille Université Access content directly
Journal Articles Therapeutic Drug Monitoring Year : 2016

Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.

Abstract

In pediatric cancer patients, determination of optimal vancomycin dosage is essential because of high risk of inadequate concentrations and bacterial resistance. The aim of this study was to determine vancomycin pharmacokinetic parameters in this population and propose dosage optimization to achieve optimal concentration.
No file

Dates and versions

hal-01776345 , version 1 (24-04-2018)

Identifiers

Cite

Romain Guilhaumou, Amelie Marsot, Julien Dupouey, Claire Galambrun, Audrey Boulamery, et al.. Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.. Therapeutic Drug Monitoring, 2016, 38 (5), pp.559 - 566. ⟨10.1097/FTD.0000000000000318⟩. ⟨hal-01776345⟩
67 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More